학술논문

Plasma SOMAmer proteomics of postoperative delirium
Document Type
article
Source
Brain and Behavior. 14(2)
Subject
Medical Biochemistry and Metabolomics
Biomedical and Clinical Sciences
Mental Health
Patient Safety
Brain Disorders
Alzheimer's Disease
Aging
Clinical Research
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Dementia
Neurodegenerative
Acquired Cognitive Impairment
Detection
screening and diagnosis
4.1 Discovery and preclinical testing of markers and technologies
Humans
Aged
Emergence Delirium
Delirium
Postoperative Complications
Case-Control Studies
Proteomics
Biomarkers
biomarkers
postoperative delirium
proteomics
Perioperative Medicine Research group
proteomics
Neurosciences
Psychology
Cognitive Sciences
Clinical sciences
Biological psychology
Language
Abstract
BackgroundPostoperative delirium is prevalent in older adults and has been shown to increase the risk of long-term cognitive decline. Plasma biomarkers to identify the risk for postoperative delirium and the risk of Alzheimer's disease and related dementias are needed.MethodsThis biomarker discovery case-control study aimed to identify plasma biomarkers associated with postoperative delirium. Patients aged ≥65 years undergoing major elective noncardiac surgery were recruited. The preoperative plasma proteome was interrogated with SOMAmer-based technology targeting 1433 biomarkers.ResultsIn 40 patients (20 with vs. 20 without postoperative delirium), a preoperative panel of 12 biomarkers discriminated patients with postoperative delirium with an accuracy of 97.5%. The final model of five biomarkers delivered a leave-one-out cross-validation accuracy of 80%. Represented biological pathways included lysosomal and immune response functions.ConclusionIn older patients who have undergone major surgery, plasma SOMAmer proteomics may provide a relatively non-invasive benchmark to identify biomarkers associated with postoperative delirium.